BerGenBio (OSE: BGBIO) is developing a pipeline of transformative drugs targeting AXL as a cornerstone of therapy for aggressive diseases, including cancer and severe respiratory infections.
NEWS
Just a few of the companies we’ve highlighted along the way
![](https://biotuesdays.com/wp-content/uploads/2024/06/1-Coverage-Logos.png)